Targeting protein prenylation for cancer therapy

Berndt, Norbert, Hamilton, Andrew D., Sebti, Saïd M.·2011·Nature Reviews Cancer
DOI 10.1038/nrc3151

Cites (221)

Items 201–222 of 222

  1. Inhibitors of Farnesyl Protein Transferase and MEK1,2 Induce Apoptosis in Fibroblasts Transformed with Farnesylated but Not Geranylgeranylated H-Ras
    Diana Brassard, Jessie M. English, Michael G. Malkowski, Paul T. Kirschmeier, Tattanahali L. Nagabhushan, Walter Robert Bishop · 2002 · Experimental Cell Research
  2. The Farnesyltransferase Inhibitor LB42708 Suppresses Vascular Endothelial Growth Factor-Induced Angiogenesis by Inhibiting Ras-dependent Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signal Pathways
    CK Kim, Yoon Kyung Choi, Hansoo Lee, Kwon‐Soo Ha, Moo‐Ho Won, Young‐Guen Kwon, Young-Myeong Kim · 2010 · Molecular Pharmacology
  3. Phosphorylation of RhoB by CK1 impedes actin stress fiber organization and epidermal growth factor receptor stabilization
    Vanessa Tillement, Isabelle Lajoie‐Mazenc, Anne Casanova, Carine Froment, Marie Pénary, Daniel Tovar, Rodolfo Márquez, Bernard Monsarrat, Gilles Favre, Anne Pradines · 2008 · Experimental Cell Research
  4. Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
    Shuzhen Chen, Lei Fu, Shruti M. Raja, Ping Yue, Fadlo Raja Khuri, Shi‐Yong Sun · 2010 · Molecular Cancer
  5. CHEMOPREVENTIVE EFFICACY OF PROMISING FARNESYLTRANSFERASE INHIBITORS
    Laura E. Lantry, Zhongqiu Zhang, Keith A. Crist, Yian Wang, Mitsunobu Hara, Axel Zeeck, Ronald A. Lubet, Ming You · 2000 · Experimental Lung Research
  6. Inactivation of farnesyltransferase and geranylgeranyltransferase I by caspase-3: Cleavage of the common α subunit during apoptosis
    Ki Woo Kim, Hyun-Ho Chung, Chul-Woong Chung, In-Ki Kim, Masayuki Miura, Suyue Wang, Hong Zhu, Kyung-Duk Moon, Geun Bae Rha, Jy-Hyun Park et al. · 2001 · Oncogene
  7. Ras homologue enriched in brain is a critical target of farnesyltransferase inhibitors in non-small cell lung cancer cells
    Hang Zheng, Anling Liu, Bin Liu, Minghui Li, Hailang Yu, Xiaojun Luo · 2010 · Cancer Letters
  8. Caution! Analyze transcripts from conditional knockout alleles
    Shao Hua Yang, Martin O. Bergö, Emily Farber, Xin Qiao, Loren G. Fong, Stephen G. Young · 2008 · Transgenic Research
  9. Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours
    Wandena S. Siegel-Lakhai, Mirjam Crul, S. Zhang, Rolf W. Sparidans, Dick Pluim, Angela J. Howes, Bhavna Solanki, Jos H. Beijnen, Jan H.M. Schellens · 2005 · British Journal of Cancer
  10. Requirement for Geranylgeranyl Transferase I and Acyl Transferase in the TGF-β-Stimulated Pathway Leading to Elastin mRNA Stabilization
    Umberto Kucich, Joan C. Rosenbloom, Gloria Shen, William R. Abrams, Michelle A. Blaskovich, Andrew D. Hamilton, Junko Ohkanda, Saı̈d M. Sebti, Joel Rosenbloom · 1998 · Biochemical and Biophysical Research Communications
  11. O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    George R. Blumenschein, Carrianne Ludwig, G. Thomas, E. Tan, M. Fanucchi, Antonio Santoro, J. Crawford, Jean Luc Breton, M. O’Brien, Fadlo Raja Khuri · 2005 · Lung Cancer
  12. α-Subunit of Farnesyltransferase Is Phosphorylatedin Vivo:Effect of Protein Phosphatase-1 on Enzymatic Activity
    Amit Kumar, Maureen H. Beresini, Punita Dhawan, Kamal D. Mehta · 1996 · Biochemical and Biophysical Research Communications
  13. Farnesyl transferase expression determines clinical response to the docetaxel‐lonafarnib combination in patients with advanced malignancies
    John Sae Wook Kauh, Chantal Chanel‐Vos, Daniel Escuín, Michael Paul Fanucchi, Robert Donald Harvey, Nabil F. Saba, Dong Moon Shin, Anthony A. Gal, Lin Pan, Michael Kutner et al. · 2011 · Cancer
  14. Increased Farnesyltransferase Activity in Human Colorectal Cancer: Relationship with Clinicopathological Features and K-ras Mutation
    Mariangela Caruso, Maria Notarnicola, Maurizio Bifulco, Carmen Laezza, Guerra V., Donato F. Altomare, Vincenzo Memeo, Lorusso ­D., Ignazio Demma, Alfredo Di Leo · 2003 · Scandinavian Journal of Gastroenterology
  15. Inactivating GGTase-I reduces disease phenotypes in a mouse model of K-RAS-induced myeloproliferative disease
    Anna-Karin M. Sjogren, Karin Andersson, Omar M. Khan, Frida J. Olofsson, C. Karlsson, Martin O. Bergö · 2010 · Leukemia
  16. Protein geranylgeranyltransferase-I of Trypanosoma cruzi
    Kohei Yokoyama, J. Robert Gillespie, Wesley C. Van Voorhis A, Frederick S. Buckner A C, Michael H. Gelb · 2007 · Molecular and Biochemical Parasitology
  17. Chromatographic Assay and Peptide Substrate Characterization of Partially Purified Farnesyl- and Geranylgeranyltransferases from Rat Brain Cytosol
    Jean Albert Boutin, William Marande, Marion Goussard, Armelle Loynel, Emmanuel Canet, Jean‐Luc Fauchère · 1998 · Archives of Biochemistry and Biophysics
  18. p21ras farnesyltransferase α- and β-subunits are phosphorylated in PC-12 cells: TGF-β signaling pathway independent phosphorylation
    Amit Kumar, Kamal D. Mehta · 1997 · Neuroscience Letters
  19. The inhibition of Ras farnesylation leads to an increase in p27Kip1 and G1 cell cycle arrest
    Hadas Reuveni, Shoshana Klein, Alexander Levitzki · 2003 · European Journal of Biochemistry
  20. Protease inhibitors prevent the protein kinase A-dependent loss of Rap1 GTPase from the particulate fraction of COS1 cells
    Catherine J. Rundell, Claire E. Repellin, Stephen J. Yarwood · 2004 · Biochemical and Biophysical Research Communications
  21. Slaying RAS with a synthetic lethal weapon
    Archana Bommi‐Reddy, William G. Kaelin · 2010 · Cell Research
  22. posters F: Phase 1 and 2 studies
    2010 · Annals of Oncology